GuiZhou SanLi Pharmaceutical Co., Ltd. (603439) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

GuiZhou SanLi Pharmaceutical Co., Ltd.

Why is GuiZhou SanLi Pharmaceutical Co., Ltd. ?

With a fall in Operating Profit of -28.31%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 2 consecutive quarters
INTEREST(HY) At CNY 7.78 MM has Grown at 27%
OPERATING CASH FLOW(Y) Lowest at CNY 87.38 MM
ROCE(HY) Lowest at 16.7%

With ROE of 16.66%, it has a expensive valuation with a 3.52 Price to Book Value

Over the past year, while the stock has generated a return of -14.65%, its profits have fallen by -21.3%
At the current price, the company has a high dividend yield of 2.7

Below par performance in long term as well as near term

Along with generating -14.65% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is GuiZhou SanLi Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

GuiZhou SanLi Pharmaceutical Co., Ltd.

-100.0%

-0.52

28.09%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.59%

EBIT Growth (5y)

13.17%

EBIT to Interest (avg)

29.90

Debt to EBITDA (avg)

0.18

Net Debt to Equity (avg)

0.20

Sales to Capital Employed (avg)

0.88

Tax Ratio

13.06%

Dividend Payout Ratio

49.87%

Pledged Shares

Institutional Holding

ROCE (avg)

18.56%

ROE (avg)

15.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.52

EV to EBIT

21.75

EV to EBITDA

16.93

EV to Capital Employed

2.80

EV to Sales

3.05

PEG Ratio

Dividend Yield

2.67%

ROCE (Latest)

12.89%

ROE (Latest)

16.66%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-26What is not working for the Company

INTEREST(HY)

At CNY 7.78 MM has Grown at 27%

OPERATING CASH FLOW(Y)

Lowest at CNY 87.38 MM

ROCE(HY)

Lowest at 16.7%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,526.84

DEBT-EQUITY RATIO (HY)

Highest at 20.49 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.37%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.66%

NET SALES(Q)

Lowest at CNY 402.71 MM

OPERATING PROFIT(Q)

Lowest at CNY 47.57 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 11.81 %

PRE-TAX PROFIT(Q)

Fallen at -29.09%

NET PROFIT(Q)

Lowest at CNY 41.95 MM

EPS(Q)

Lowest at CNY 0.1

Here's what is not working for GuiZhou SanLi Pharmaceutical Co., Ltd.

Interest

At CNY 7.78 MM has Grown at 27%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,526.84

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 87.38 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 402.71 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 47.57 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 11.81 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 47.98 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

Fallen at -29.09%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 41.95 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.1

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio

Highest at 20.49 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.37%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.66%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio